The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.

Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.

A study found a potential causal link between rheumatoid arthritis and increased prostate cancer risk. Researchers used ...

Montrealer Michael Santillo was 29 when he was diagnosed with ankylosing spondylitis, a type of inflammatory arthritis. It ...

An 81-year-old man with longstanding ankylosing spondylitis presented to the emergency department with pain in his lower back 2 days after a fall from standing height. The pain from the injury made it ...

A project based in a Nottinghamshire town is helping the community by getting young people hooked on fishing. Mending Lines ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...

Discover how biologic therapies impact infection risks in ankylosing spondylitis (AS) patients. A KOBIO registry study ...

The following is a summary of “Incidence and risk of infections in patients with ankylosing spondylitis receiving biologic ...

Ankylosing spondylitis is a type of arthritis that primarily affects the spine. Symptoms of this lifelong condition usually begin in early adulthood and include pain and stiffness in the lower back.